Entities / Company
Arbutus Biopharma.
Canadian Bio Tech Company
- Reports this week
- 3
- Active events
- 3
- Connections
- 25
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Arbutus Biopharma and Evaxion A/S are identified as small-cap healthcare companies.Some support1 report
-
Arbutus Biopharma and Prelude Therapeutics are identified as small-cap healthcare companies.Some support1 report
-
Both Arbutus Biopharma and Prelude Therapeutics are small-cap healthcare companies, with Arbutus having higher revenue and earnings.Some support1 report
Earlier this month
Gone quiet
No new reports in 90+ days-
Arbutus Biopharma stock was added to the Russell 2000 Defensive and Growth Defensive Indexes on July 9, 2026.Some support1 report
-
Harry L.A. Janssen joined the Arbutus Scientific Advisory Board, while Anuj was appointed VP at Vertex. Janssen also maintains ties with Erasmus MC in Rotterdam.Some support2 reports
-
Arbutus Biopharma operates within the biomedical and genetics sector, and its stock performance was compared to the S&P 500.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Arbutus Biopharma this week
News at the entities that move Arbutus Biopharma most-
MarketBeat StructuralMarketBeat reported on MIND Technology and Transocean stocks, comparing them as energy companies.Moves Arbutus Biopharma
-
Pfizer OperationalPfizer facilities in Rocky Mount, NC, face potential layoffs that could affect the local economy.Moves Arbutus Biopharma
Connections
The 3 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MarketBeat Structural
Arbutus Biopharma utilizes MarketBeat as its financial data reporting platform.
-
Pfizer Operational
Arbutus Biopharma has initiated patent lawsuits against Pfizer.
-
Medical Shared context
Arbutus Biopharma is contextualized within the Medical sector.
History
Events by the month they beganOctober 2026
4 events- Arbutus Biopharma and Evaxion A/S are identified as small-cap healthcare companies.
- Arbutus Biopharma and Prelude Therapeutics are identified as small-cap healthcare companies.
- Both Arbutus Biopharma and Prelude Therapeutics are small-cap healthcare companies, with Arbutus having higher revenue and earnings.
- Arbutus Biopharma and Immunome, Inc. are currently competing for investment funding as healthcare companies.